Compound ID | 1048
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Propensity to select resistant mutants: | Yes |
| Institute where first reported: | Pfizer Inc |
| Year first mentioned: | 1975 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| Reason dropped: | Disappointing clinical results-only found mention of this once however |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9871712 |
| Guide to Pharmacology: | pirbenicillin |
| Citations: |
|